feed,title,long_url,short_url
Investing,PepGen gains FDA orphan drug status for DMD treatment,https://www.investing.com/news/stock-market-news/pepgen-gains-fda-orphan-drug-status-for-dmd-treatment-93CH-3335770,https://da.gd/fEmWlO
Investing,"DA Davidson remains bullish on Veritex, maintains buy rating and stock PT",https://www.investing.com/news/stock-market-news/da-davidson-remains-bullish-on-veritex-maintains-buy-rating-and-stock-pt-93CH-3335768,https://da.gd/FicMUK
Investing,HUYA Inc. appoints new director to its board,https://www.investing.com/news/stock-market-news/huya-inc-appoints-new-director-to-its-board-93CH-3335767,https://da.gd/dxHnJ
Investing,Exclusive-Italy in talks with China's Chery on car plant,https://www.investing.com/news/stock-market-news/exclusiveitaly-in-talks-with-chinas-chery-on-car-plant-3335766,https://da.gd/A5LTe
Investing,"Roth/MKM lifts Laird Superfoods shares on Strong Q4 margin, revenue growth",https://www.investing.com/news/stock-market-news/rothmkm-lifts-laird-superfoods-shares-on-strong-q4-margin-revenue-growth-93CH-3335757,https://da.gd/17NI
Investing,Needham raises Heron Therapeutics stock PT to $5 on 'strong 2023 finish',https://www.investing.com/news/stock-market-news/needham-raises-heron-therapeutics-stock-pt-to-5-on-strong-2023-finish-93CH-3335746,https://da.gd/WO6mlr
Investing,Dollar Tree (NASDAQ:DLTR) Reports Q4 In Line With Expectations But Stock Drops on Guidance,https://www.investing.com/news/stock-market-news/dollar-tree-nasdaqdltr-reports-q4-in-line-with-expectations-but-stock-drops-on-guidance-3335744,https://da.gd/YJ5xTQ
Investing,Voyager Therapeutics names ex-Biogen VP as new Chief Medical Officer,https://www.investing.com/news/stock-market-news/voyager-therapeutics-names-exbiogen-vp-as-new-chief-medical-officer-93CH-3335742,https://da.gd/9cfk
Investing,BioCardia partners with StemCardia for heart therapy,https://www.investing.com/news/stock-market-news/biocardia-partners-with-stemcardia-for-heart-therapy-93CH-3335735,https://da.gd/VBu1g3
